Subject: Jacobs Gets Liposome Contract
Date: Published: 3/12/92 (25 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    Technology:
    Jacobs Gets Liposome Contract

    PASADENA, Calif.  -- Jacobs Engineering Group Inc. said it
 received a contract to provide engineering services for a
 manufacturing plant owned by Liposome Co. of Princeton, N. J. 
 The company wouldn't disclose the value of the contract, but
 analysts placed it between $10 million and $20 million.
    Jacobs also would provide process engineering for the
 manufacture of Liposome's TLC G-65 drug, which is being
 developed to treat Mycobacterium avium-intracellulare in AIDS
 patients.
    The new drug is a potential major product for Liposome,
 according to Linda L. Miller, an analyst for PaineWebber
 Group.  Jacobs is an engineering, design, waste-management and
 construction company.  Liposome develops products used to
 enhance pharmaceuticals.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]